Table II.
Mutant | Substrate for | Growth | Protein synthesis | |
---|---|---|---|---|
DHS | DOHH | |||
Wild type | +++ | + | + | + |
K47A | +++ | + | s.g. | n.d. |
K47D | +++ | − | − | − |
K47R | +++ | + | + | + |
G49Aa | +++ | + | − | n.d. |
K50A | − | − | − | n.d. |
K50D | − | − | − | n.d. |
K50I | − | − | − | n.d. |
K50R | − | − | − | − |
H51A | +++ | − | s.g. | n.d. |
G52Aa | + | + | − | n.d. |
K55A | + | + | − | n.d. |
P74A | ++ | + | s.g. | n.d. |
L91Ab | ++ | + | s.g. | n.d. |
L101Ab | ++ | + | s.g. | n.d. |
In addition to the deoxyhypusine/hypusine at residue 50, these two glycine residues are likely the most critical residues in eIF5A/effector interactions.
These proteins appear to be unstable and their cellular levels were low.